Document is current

Any future updates will be listed below

Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)

Crossref DOI link: https://doi.org/10.1186/s12885-017-3261-1

Published Online: 2017-04-13

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark